Angel One stock initiated with Neutral rating by UBS on regulatory risks

UBS initiated Neutral coverage on Angel One Ltd, India's third-largest retail broker, citing regulatory uncertainties and valuation concerns. The investment bank projects a 7% year-over-year revenue decline for Angel One in fiscal year 2026, primarily due to an estimated 15% drop in equity derivatives orders amid potential market speculation curbs. UBS's forecast for gross brokerage income CAGR (9% over FY25-28E) is notably below Angel One's 16.9% estimate, although UBS anticipates normalization by late FY26, projecting a 10.4% revenue CAGR for the period.

Analysis

UBS has initiated coverage on Angel One Ltd (NSE:ANGELONE) with a Neutral rating, reflecting a balance between near-term headwinds and long-term market growth. The primary concern stems from regulatory uncertainty, with potential government measures to curb market speculation expected to significantly impact trading volumes. Specifically, UBS forecasts a 15% drop in equity derivatives orders, which is projected to drive a 7% year-over-year revenue decline for Angel One in fiscal year 2026. This is particularly impactful as brokerage income constitutes 63% of the company's FY25 revenue. A stark divergence in outlook is evident, with UBS projecting a 9% compound annual growth rate (CAGR) for gross brokerage income over FY25-28, substantially below Angel One's own estimate of 16.9%. Despite these challenges, UBS anticipates a normalization in trading activity by late FY26 and projects a 10.4% revenue CAGR for FY25-28, slightly above the 9.1% growth rate implied by the current market price, which likely underpins the Neutral stance rather than a more bearish rating.

Key Decisions for Investors

• Investors should closely monitor Indian regulatory announcements regarding market speculation, as this is the primary identified risk factor driving the forecasted revenue decline for FY26.
• The significant disparity between Angel One's optimistic 16.9% growth guidance and UBS's more conservative 9% forecast warrants caution; a prudent approach would be to track actual derivatives order volumes to validate either thesis.
• Given the Neutral rating and a long-term forecast slightly ahead of the market-implied growth rate, current positions may be held pending regulatory clarity, as near-term risks appear to be a key component of the current valuation.